Service & Software
AI in Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 656442
- Pages: 84
- Figures: 158
- Views: 1
The global market for AI in Pharmaceutical was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AI in Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI in Pharmaceutical by region & country, by Type, and by Application.
The AI in Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI in Pharmaceutical.
Market Segmentation
By Company
Google LLC.
Intel Corporation
Sanofi
Eli Lilly and Company
IBM Corporation
Exscientia
Iktos
Biovista
Segment by Type:
Smartphones and Tablets
Wearables
Workstation Systems
Medical Devices
Autonomous Robots
Imaging Systems
Others
Segment by Application
Hospitals and Providers
Pharmaceutical and Biotechnology companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of AI in Pharmaceutical manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of AI in Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of AI in Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AI in Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI in Pharmaceutical by region & country, by Type, and by Application.
The AI in Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI in Pharmaceutical.
Market Segmentation
By Company
Google LLC.
Intel Corporation
Sanofi
Eli Lilly and Company
IBM Corporation
Exscientia
Iktos
Biovista
Segment by Type:
Smartphones and Tablets
Wearables
Workstation Systems
Medical Devices
Autonomous Robots
Imaging Systems
Others
Segment by Application
Hospitals and Providers
Pharmaceutical and Biotechnology companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of AI in Pharmaceutical manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of AI in Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of AI in Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 AI in Pharmaceutical Product Introduction
1.2 Global AI in Pharmaceutical Market Size Forecast
1.3 AI in Pharmaceutical Market Trends & Drivers
1.3.1 AI in Pharmaceutical Industry Trends
1.3.2 AI in Pharmaceutical Market Drivers & Opportunity
1.3.3 AI in Pharmaceutical Market Challenges
1.3.4 AI in Pharmaceutical Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI in Pharmaceutical Players Revenue Ranking (2023)
2.2 Global AI in Pharmaceutical Revenue by Company (2019-2024)
2.3 Key Companies AI in Pharmaceutical Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI in Pharmaceutical Product Offered
2.5 Key Companies Time to Begin Mass Production of AI in Pharmaceutical
2.6 AI in Pharmaceutical Market Competitive Analysis
2.6.1 AI in Pharmaceutical Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by AI in Pharmaceutical Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Pharmaceutical as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Smartphones and Tablets
3.1.2 Wearables
3.1.3 Workstation Systems
3.1.4 Medical Devices
3.1.5 Autonomous Robots
3.1.6 Imaging Systems
3.1.7 Others
3.2 Global AI in Pharmaceutical Sales Value by Type
3.2.1 Global AI in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global AI in Pharmaceutical Sales Value, by Type (2019-2030)
3.2.3 Global AI in Pharmaceutical Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Providers
4.1.2 Pharmaceutical and Biotechnology companies
4.1.3 Others
4.2 Global AI in Pharmaceutical Sales Value by Application
4.2.1 Global AI in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global AI in Pharmaceutical Sales Value, by Application (2019-2030)
4.2.3 Global AI in Pharmaceutical Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global AI in Pharmaceutical Sales Value by Region
5.1.1 Global AI in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global AI in Pharmaceutical Sales Value by Region (2019-2024)
5.1.3 Global AI in Pharmaceutical Sales Value by Region (2025-2030)
5.1.4 Global AI in Pharmaceutical Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America AI in Pharmaceutical Sales Value, 2019-2030
5.2.2 North America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe AI in Pharmaceutical Sales Value, 2019-2030
5.3.2 Europe AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific AI in Pharmaceutical Sales Value, 2019-2030
5.4.2 Asia Pacific AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America AI in Pharmaceutical Sales Value, 2019-2030
5.5.2 South America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI in Pharmaceutical Sales Value, 2019-2030
5.6.2 Middle East & Africa AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI in Pharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions AI in Pharmaceutical Sales Value
6.3 United States
6.3.1 United States AI in Pharmaceutical Sales Value, 2019-2030
6.3.2 United States AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.3.3 United States AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe AI in Pharmaceutical Sales Value, 2019-2030
6.4.2 Europe AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China AI in Pharmaceutical Sales Value, 2019-2030
6.5.2 China AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.5.3 China AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan AI in Pharmaceutical Sales Value, 2019-2030
6.6.2 Japan AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea AI in Pharmaceutical Sales Value, 2019-2030
6.7.2 South Korea AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia AI in Pharmaceutical Sales Value, 2019-2030
6.8.2 Southeast Asia AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India AI in Pharmaceutical Sales Value, 2019-2030
6.9.2 India AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.9.3 India AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Google LLC.
7.1.1 Google LLC. Profile
7.1.2 Google LLC. Main Business
7.1.3 Google LLC. AI in Pharmaceutical Products, Services and Solutions
7.1.4 Google LLC. AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.1.5 Google LLC. Recent Developments
7.2 Intel Corporation
7.2.1 Intel Corporation Profile
7.2.2 Intel Corporation Main Business
7.2.3 Intel Corporation AI in Pharmaceutical Products, Services and Solutions
7.2.4 Intel Corporation AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.2.5 Intel Corporation Recent Developments
7.3 Sanofi
7.3.1 Sanofi Profile
7.3.2 Sanofi Main Business
7.3.3 Sanofi AI in Pharmaceutical Products, Services and Solutions
7.3.4 Sanofi AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.3.5 Eli Lilly and Company Recent Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Profile
7.4.2 Eli Lilly and Company Main Business
7.4.3 Eli Lilly and Company AI in Pharmaceutical Products, Services and Solutions
7.4.4 Eli Lilly and Company AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.4.5 Eli Lilly and Company Recent Developments
7.5 IBM Corporation
7.5.1 IBM Corporation Profile
7.5.2 IBM Corporation Main Business
7.5.3 IBM Corporation AI in Pharmaceutical Products, Services and Solutions
7.5.4 IBM Corporation AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.5.5 IBM Corporation Recent Developments
7.6 Exscientia
7.6.1 Exscientia Profile
7.6.2 Exscientia Main Business
7.6.3 Exscientia AI in Pharmaceutical Products, Services and Solutions
7.6.4 Exscientia AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.6.5 Exscientia Recent Developments
7.7 Iktos
7.7.1 Iktos Profile
7.7.2 Iktos Main Business
7.7.3 Iktos AI in Pharmaceutical Products, Services and Solutions
7.7.4 Iktos AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.7.5 Iktos Recent Developments
7.8 Biovista
7.8.1 Biovista Profile
7.8.2 Biovista Main Business
7.8.3 Biovista AI in Pharmaceutical Products, Services and Solutions
7.8.4 Biovista AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.8.5 Biovista Recent Developments
8 Industry Chain Analysis
8.1 AI in Pharmaceutical Industrial Chain
8.2 AI in Pharmaceutical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI in Pharmaceutical Sales Model
8.5.2 Sales Channel
8.5.3 AI in Pharmaceutical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 AI in Pharmaceutical Product Introduction
1.2 Global AI in Pharmaceutical Market Size Forecast
1.3 AI in Pharmaceutical Market Trends & Drivers
1.3.1 AI in Pharmaceutical Industry Trends
1.3.2 AI in Pharmaceutical Market Drivers & Opportunity
1.3.3 AI in Pharmaceutical Market Challenges
1.3.4 AI in Pharmaceutical Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI in Pharmaceutical Players Revenue Ranking (2023)
2.2 Global AI in Pharmaceutical Revenue by Company (2019-2024)
2.3 Key Companies AI in Pharmaceutical Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI in Pharmaceutical Product Offered
2.5 Key Companies Time to Begin Mass Production of AI in Pharmaceutical
2.6 AI in Pharmaceutical Market Competitive Analysis
2.6.1 AI in Pharmaceutical Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by AI in Pharmaceutical Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Pharmaceutical as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Smartphones and Tablets
3.1.2 Wearables
3.1.3 Workstation Systems
3.1.4 Medical Devices
3.1.5 Autonomous Robots
3.1.6 Imaging Systems
3.1.7 Others
3.2 Global AI in Pharmaceutical Sales Value by Type
3.2.1 Global AI in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global AI in Pharmaceutical Sales Value, by Type (2019-2030)
3.2.3 Global AI in Pharmaceutical Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Providers
4.1.2 Pharmaceutical and Biotechnology companies
4.1.3 Others
4.2 Global AI in Pharmaceutical Sales Value by Application
4.2.1 Global AI in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global AI in Pharmaceutical Sales Value, by Application (2019-2030)
4.2.3 Global AI in Pharmaceutical Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global AI in Pharmaceutical Sales Value by Region
5.1.1 Global AI in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global AI in Pharmaceutical Sales Value by Region (2019-2024)
5.1.3 Global AI in Pharmaceutical Sales Value by Region (2025-2030)
5.1.4 Global AI in Pharmaceutical Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America AI in Pharmaceutical Sales Value, 2019-2030
5.2.2 North America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe AI in Pharmaceutical Sales Value, 2019-2030
5.3.2 Europe AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific AI in Pharmaceutical Sales Value, 2019-2030
5.4.2 Asia Pacific AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America AI in Pharmaceutical Sales Value, 2019-2030
5.5.2 South America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI in Pharmaceutical Sales Value, 2019-2030
5.6.2 Middle East & Africa AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI in Pharmaceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions AI in Pharmaceutical Sales Value
6.3 United States
6.3.1 United States AI in Pharmaceutical Sales Value, 2019-2030
6.3.2 United States AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.3.3 United States AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe AI in Pharmaceutical Sales Value, 2019-2030
6.4.2 Europe AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China AI in Pharmaceutical Sales Value, 2019-2030
6.5.2 China AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.5.3 China AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan AI in Pharmaceutical Sales Value, 2019-2030
6.6.2 Japan AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea AI in Pharmaceutical Sales Value, 2019-2030
6.7.2 South Korea AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia AI in Pharmaceutical Sales Value, 2019-2030
6.8.2 Southeast Asia AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India AI in Pharmaceutical Sales Value, 2019-2030
6.9.2 India AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
6.9.3 India AI in Pharmaceutical Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Google LLC.
7.1.1 Google LLC. Profile
7.1.2 Google LLC. Main Business
7.1.3 Google LLC. AI in Pharmaceutical Products, Services and Solutions
7.1.4 Google LLC. AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.1.5 Google LLC. Recent Developments
7.2 Intel Corporation
7.2.1 Intel Corporation Profile
7.2.2 Intel Corporation Main Business
7.2.3 Intel Corporation AI in Pharmaceutical Products, Services and Solutions
7.2.4 Intel Corporation AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.2.5 Intel Corporation Recent Developments
7.3 Sanofi
7.3.1 Sanofi Profile
7.3.2 Sanofi Main Business
7.3.3 Sanofi AI in Pharmaceutical Products, Services and Solutions
7.3.4 Sanofi AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.3.5 Eli Lilly and Company Recent Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Profile
7.4.2 Eli Lilly and Company Main Business
7.4.3 Eli Lilly and Company AI in Pharmaceutical Products, Services and Solutions
7.4.4 Eli Lilly and Company AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.4.5 Eli Lilly and Company Recent Developments
7.5 IBM Corporation
7.5.1 IBM Corporation Profile
7.5.2 IBM Corporation Main Business
7.5.3 IBM Corporation AI in Pharmaceutical Products, Services and Solutions
7.5.4 IBM Corporation AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.5.5 IBM Corporation Recent Developments
7.6 Exscientia
7.6.1 Exscientia Profile
7.6.2 Exscientia Main Business
7.6.3 Exscientia AI in Pharmaceutical Products, Services and Solutions
7.6.4 Exscientia AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.6.5 Exscientia Recent Developments
7.7 Iktos
7.7.1 Iktos Profile
7.7.2 Iktos Main Business
7.7.3 Iktos AI in Pharmaceutical Products, Services and Solutions
7.7.4 Iktos AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.7.5 Iktos Recent Developments
7.8 Biovista
7.8.1 Biovista Profile
7.8.2 Biovista Main Business
7.8.3 Biovista AI in Pharmaceutical Products, Services and Solutions
7.8.4 Biovista AI in Pharmaceutical Revenue (US$ Million) & (2019-2024)
7.8.5 Biovista Recent Developments
8 Industry Chain Analysis
8.1 AI in Pharmaceutical Industrial Chain
8.2 AI in Pharmaceutical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI in Pharmaceutical Sales Model
8.5.2 Sales Channel
8.5.3 AI in Pharmaceutical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. AI in Pharmaceutical Market Trends
Table 2. AI in Pharmaceutical Market Drivers & Opportunity
Table 3. AI in Pharmaceutical Market Challenges
Table 4. AI in Pharmaceutical Market Restraints
Table 5. Global AI in Pharmaceutical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global AI in Pharmaceutical Revenue Market Share by Company (2019-2024)
Table 7. Key Companies AI in Pharmaceutical Manufacturing Base Distribution and Headquarters
Table 8. Key Companies AI in Pharmaceutical Product Type
Table 9. Key Companies Time to Begin Mass Production of AI in Pharmaceutical
Table 10. Global AI in Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Pharmaceutical as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global AI in Pharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global AI in Pharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global AI in Pharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global AI in Pharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global AI in Pharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global AI in Pharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global AI in Pharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global AI in Pharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global AI in Pharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global AI in Pharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global AI in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global AI in Pharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global AI in Pharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global AI in Pharmaceutical Sales Value by Region (2019-2024) & (%)
Table 27. Global AI in Pharmaceutical Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions AI in Pharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions AI in Pharmaceutical Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions AI in Pharmaceutical Sales Value, (2025-2030) & (US$ Million)
Table 31. Google LLC. Basic Information List
Table 32. Google LLC. Description and Business Overview
Table 33. Google LLC. AI in Pharmaceutical Products, Services and Solutions
Table 34. Revenue (US$ Million) in AI in Pharmaceutical Business of Google LLC. (2019-2024)
Table 35. Google LLC. Recent Developments
Table 36. Intel Corporation Basic Information List
Table 37. Intel Corporation Description and Business Overview
Table 38. Intel Corporation AI in Pharmaceutical Products, Services and Solutions
Table 39. Revenue (US$ Million) in AI in Pharmaceutical Business of Intel Corporation (2019-2024)
Table 40. Intel Corporation Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi AI in Pharmaceutical Products, Services and Solutions
Table 44. Revenue (US$ Million) in AI in Pharmaceutical Business of Sanofi (2019-2024)
Table 45. Sanofi Recent Developments
Table 46. Eli Lilly and Company Basic Information List
Table 47. Eli Lilly and Company Description and Business Overview
Table 48. Eli Lilly and Company AI in Pharmaceutical Products, Services and Solutions
Table 49. Revenue (US$ Million) in AI in Pharmaceutical Business of Eli Lilly and Company (2019-2024)
Table 50. Eli Lilly and Company Recent Developments
Table 51. IBM Corporation Basic Information List
Table 52. IBM Corporation Description and Business Overview
Table 53. IBM Corporation AI in Pharmaceutical Products, Services and Solutions
Table 54. Revenue (US$ Million) in AI in Pharmaceutical Business of IBM Corporation (2019-2024)
Table 55. IBM Corporation Recent Developments
Table 56. Exscientia Basic Information List
Table 57. Exscientia Description and Business Overview
Table 58. Exscientia AI in Pharmaceutical Products, Services and Solutions
Table 59. Revenue (US$ Million) in AI in Pharmaceutical Business of Exscientia (2019-2024)
Table 60. Exscientia Recent Developments
Table 61. Iktos Basic Information List
Table 62. Iktos Description and Business Overview
Table 63. Iktos AI in Pharmaceutical Products, Services and Solutions
Table 64. Revenue (US$ Million) in AI in Pharmaceutical Business of Iktos (2019-2024)
Table 65. Iktos Recent Developments
Table 66. Biovista Basic Information List
Table 67. Biovista Description and Business Overview
Table 68. Biovista AI in Pharmaceutical Products, Services and Solutions
Table 69. Revenue (US$ Million) in AI in Pharmaceutical Business of Biovista (2019-2024)
Table 70. Biovista Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. AI in Pharmaceutical Downstream Customers
Table 74. AI in Pharmaceutical Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. AI in Pharmaceutical Product Picture
Figure 2. Global AI in Pharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. AI in Pharmaceutical Report Years Considered
Figure 5. Global AI in Pharmaceutical Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by AI in Pharmaceutical Revenue in 2023
Figure 7. AI in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Smartphones and Tablets Picture
Figure 9. Wearables Picture
Figure 10. Workstation Systems Picture
Figure 11. Medical Devices Picture
Figure 12. Autonomous Robots Picture
Figure 13. Imaging Systems Picture
Figure 14. Others Picture
Figure 15. Global AI in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global AI in Pharmaceutical Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Hospitals and Providers
Figure 18. Product Picture of Pharmaceutical and Biotechnology companies
Figure 19. Product Picture of Others
Figure 20. Global AI in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global AI in Pharmaceutical Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 23. North America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 28. South America AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 29. South America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions AI in Pharmaceutical Sales Value (%), (2019-2030)
Figure 33. United States AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 35. United States AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 39. China AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 40. China AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 41. China AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 51. India AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 52. India AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 53. India AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 54. AI in Pharmaceutical Industrial Chain
Figure 55. AI in Pharmaceutical Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Table 1. AI in Pharmaceutical Market Trends
Table 2. AI in Pharmaceutical Market Drivers & Opportunity
Table 3. AI in Pharmaceutical Market Challenges
Table 4. AI in Pharmaceutical Market Restraints
Table 5. Global AI in Pharmaceutical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global AI in Pharmaceutical Revenue Market Share by Company (2019-2024)
Table 7. Key Companies AI in Pharmaceutical Manufacturing Base Distribution and Headquarters
Table 8. Key Companies AI in Pharmaceutical Product Type
Table 9. Key Companies Time to Begin Mass Production of AI in Pharmaceutical
Table 10. Global AI in Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Pharmaceutical as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global AI in Pharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global AI in Pharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global AI in Pharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global AI in Pharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global AI in Pharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global AI in Pharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global AI in Pharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global AI in Pharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global AI in Pharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global AI in Pharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global AI in Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global AI in Pharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global AI in Pharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global AI in Pharmaceutical Sales Value by Region (2019-2024) & (%)
Table 27. Global AI in Pharmaceutical Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions AI in Pharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions AI in Pharmaceutical Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions AI in Pharmaceutical Sales Value, (2025-2030) & (US$ Million)
Table 31. Google LLC. Basic Information List
Table 32. Google LLC. Description and Business Overview
Table 33. Google LLC. AI in Pharmaceutical Products, Services and Solutions
Table 34. Revenue (US$ Million) in AI in Pharmaceutical Business of Google LLC. (2019-2024)
Table 35. Google LLC. Recent Developments
Table 36. Intel Corporation Basic Information List
Table 37. Intel Corporation Description and Business Overview
Table 38. Intel Corporation AI in Pharmaceutical Products, Services and Solutions
Table 39. Revenue (US$ Million) in AI in Pharmaceutical Business of Intel Corporation (2019-2024)
Table 40. Intel Corporation Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi AI in Pharmaceutical Products, Services and Solutions
Table 44. Revenue (US$ Million) in AI in Pharmaceutical Business of Sanofi (2019-2024)
Table 45. Sanofi Recent Developments
Table 46. Eli Lilly and Company Basic Information List
Table 47. Eli Lilly and Company Description and Business Overview
Table 48. Eli Lilly and Company AI in Pharmaceutical Products, Services and Solutions
Table 49. Revenue (US$ Million) in AI in Pharmaceutical Business of Eli Lilly and Company (2019-2024)
Table 50. Eli Lilly and Company Recent Developments
Table 51. IBM Corporation Basic Information List
Table 52. IBM Corporation Description and Business Overview
Table 53. IBM Corporation AI in Pharmaceutical Products, Services and Solutions
Table 54. Revenue (US$ Million) in AI in Pharmaceutical Business of IBM Corporation (2019-2024)
Table 55. IBM Corporation Recent Developments
Table 56. Exscientia Basic Information List
Table 57. Exscientia Description and Business Overview
Table 58. Exscientia AI in Pharmaceutical Products, Services and Solutions
Table 59. Revenue (US$ Million) in AI in Pharmaceutical Business of Exscientia (2019-2024)
Table 60. Exscientia Recent Developments
Table 61. Iktos Basic Information List
Table 62. Iktos Description and Business Overview
Table 63. Iktos AI in Pharmaceutical Products, Services and Solutions
Table 64. Revenue (US$ Million) in AI in Pharmaceutical Business of Iktos (2019-2024)
Table 65. Iktos Recent Developments
Table 66. Biovista Basic Information List
Table 67. Biovista Description and Business Overview
Table 68. Biovista AI in Pharmaceutical Products, Services and Solutions
Table 69. Revenue (US$ Million) in AI in Pharmaceutical Business of Biovista (2019-2024)
Table 70. Biovista Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. AI in Pharmaceutical Downstream Customers
Table 74. AI in Pharmaceutical Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. AI in Pharmaceutical Product Picture
Figure 2. Global AI in Pharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. AI in Pharmaceutical Report Years Considered
Figure 5. Global AI in Pharmaceutical Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by AI in Pharmaceutical Revenue in 2023
Figure 7. AI in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Smartphones and Tablets Picture
Figure 9. Wearables Picture
Figure 10. Workstation Systems Picture
Figure 11. Medical Devices Picture
Figure 12. Autonomous Robots Picture
Figure 13. Imaging Systems Picture
Figure 14. Others Picture
Figure 15. Global AI in Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global AI in Pharmaceutical Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Hospitals and Providers
Figure 18. Product Picture of Pharmaceutical and Biotechnology companies
Figure 19. Product Picture of Others
Figure 20. Global AI in Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global AI in Pharmaceutical Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 23. North America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 28. South America AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 29. South America AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa AI in Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa AI in Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions AI in Pharmaceutical Sales Value (%), (2019-2030)
Figure 33. United States AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 35. United States AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 39. China AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 40. China AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 41. China AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 51. India AI in Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 52. India AI in Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 53. India AI in Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 54. AI in Pharmaceutical Industrial Chain
Figure 55. AI in Pharmaceutical Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232